clinical trial · NCT03684018
Two Dose Levels of Privigen in Pediatric CIDP
CSL Behring·phase4·recruiting·n = 30
Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)IgPro10
brief summary
A randomized, open-label, prospective, multicenter study designed to investigate 2 dose levels in pediatric subjects 2 to ≤ 17 years of age with confirmed or possible CIDP, either previously exposed to IVIG treatment or unexposed to IVIG treatment
started
Feb 28, 2019
primary completion
Dec 20, 2029
completion
Dec 20, 2029
last updated
Jun 1, 2026
official title
Randomized Study of Two Dose Levels of Privigen in Pediatric CIDP
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol